Cornerstone Advisory LLC Buys 132 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cornerstone Advisory LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,930 shares of the healthcare conglomerate’s stock after purchasing an additional 132 shares during the period. Cornerstone Advisory LLC’s holdings in UnitedHealth Group were worth $1,542,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. WealthPlan Investment Management LLC raised its holdings in shares of UnitedHealth Group by 774.0% in the third quarter. WealthPlan Investment Management LLC now owns 673 shares of the healthcare conglomerate’s stock valued at $339,000 after purchasing an additional 596 shares during the last quarter. Millington Financial Advisors LLC raised its holdings in shares of UnitedHealth Group by 2.7% in the third quarter. Millington Financial Advisors LLC now owns 3,156 shares of the healthcare conglomerate’s stock valued at $1,591,000 after purchasing an additional 82 shares during the last quarter. Moody Aldrich Partners LLC bought a new stake in UnitedHealth Group during the third quarter worth $581,000. Thompson Siegel & Walmsley LLC raised its position in UnitedHealth Group by 44.0% during the third quarter. Thompson Siegel & Walmsley LLC now owns 8,246 shares of the healthcare conglomerate’s stock worth $4,158,000 after acquiring an additional 2,520 shares in the last quarter. Finally, RiverPark Advisors LLC raised its position in UnitedHealth Group by 4.8% during the third quarter. RiverPark Advisors LLC now owns 5,739 shares of the healthcare conglomerate’s stock worth $2,894,000 after acquiring an additional 261 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Up 1.6 %

UnitedHealth Group stock traded up $8.05 during mid-day trading on Tuesday, hitting $505.49. 3,158,827 shares of the stock were exchanged, compared to its average volume of 4,199,425. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The firm’s fifty day simple moving average is $489.82 and its two-hundred day simple moving average is $508.65. The stock has a market capitalization of $465.25 billion, a price-to-earnings ratio of 30.73, a PEG ratio of 1.44 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the business earned $6.26 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on UNH. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Truist Financial restated a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Finally, HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target on the stock in a research note on Thursday, April 4th. Four investment analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $572.75.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.